StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.53+0.09 (+2.03%)

Close on Nov 18, 2026Market cap $294.61MP/E –Yield –

Treace Medical Concepts operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Treace Medical Concepts's operating income for the twelve months ending Jun 30, 2026 was -$53.72M. For fiscal 2025 it was -$54.15M. The highest annual figure on record is $855.00K in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$54.15M–
FY2024Dec 31, 2024-$55.69M–
FY2023Dec 31, 2023-$51.43M–
FY2022Dec 31, 2022-$34.84M–
FY2021Dec 31, 2021-$16.51M-2031.0%
FY2020Dec 31, 2020$855.00K–
FY2019Dec 31, 2019-$3.54M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$14.96M–
Q1 FY2026Mar 31, 2026-$17.17M–
Q4 FY2025Dec 31, 2025-$5.92M–
Q3 FY2025Sep 30, 2025-$15.68M–
Q2 FY2025Jun 30, 2025-$16.97M–
Q1 FY2025Mar 31, 2025-$15.58M–
Q4 FY2024Dec 31, 2024-$204.00K–
Q3 FY2024Sep 30, 2024-$15.13M–
Q2 FY2024Jun 30, 2024-$21.38M–
Q1 FY2024Mar 31, 2024-$18.97M–
Q4 FY2023Dec 31, 2023-$6.78M–
Q3 FY2023Sep 30, 2023-$17.82M–
Q2 FY2023Jun 30, 2023-$13.05M–
Q1 FY2023Mar 31, 2023-$13.78M–
Q4 FY2022Dec 31, 2022-$3.50M–
Q3 FY2022Sep 30, 2022-$11.32M–
Q2 FY2022Jun 30, 2022-$11.93M–
Q1 FY2022Mar 31, 2022-$8.10M–
Q4 FY2021Dec 31, 2021-$5.60M-254.0%
Q3 FY2021Sep 30, 2021-$5.46M–
Q2 FY2021Jun 30, 2021-$4.05M–
Q1 FY2021Mar 31, 2021-$1.40M–
Q4 FY2020Dec 31, 2020$3.64M–
Q3 FY2020Sep 30, 2020-$63.00K–
Q2 FY2020Jun 30, 2020-$1.52M–
Q1 FY2020Mar 31, 2020-$1.20M–

More Treace Medical Concepts figures

See a number that looks wrong?